Red Blood Cell Distribution Width and Charlson Comorbidity Indeces in the Frail Polytraumatized Patient.

Sponsor

Medical University of Vienna (Other)

Overall Status

Completed

CT.gov ID

NCT05221476

Collaborator

(none)

400

Enrollment

Actual Duration (Months)

Study Details

Study Description

Brief Summary

In this study patients who were admitted to our hospital with critical injuries were enrolled retrospectively from January 2012 to December 2015. Patients with an ISS>16 points, an AIS >3 in one body region and at least 2 different body regions affected were included. RDW values on admission as well as preexisting comorbidities were evaluated.

Condition or Disease	Intervention/Treatment	Phase
Polytrauma Red Blood Cell Distribution Width Comorbidities and Coexisting Conditions	Other: retrospective

Study Design

Study Type:

Observational

Actual Enrollment :

400 participants

Observational Model:

Cohort

Time Perspective:

Retrospective

Official Title:

RDW and CCI in the Frail Polytraumatized Patients. A Retrospective Cohort Study in a Level 1 Trauma Center.

Actual Study Start Date :

Jan 1, 2012

Actual Primary Completion Date :

Dec 1, 2015

Actual Study Completion Date :

Dec 1, 2015

Arms and Interventions

Arm	Intervention/Treatment
polytraumatized patients Patients with an ISS >16 points, an AIS >3 in one body region and at least 2 different body regions affected were included.	Other: retrospective The investigators retrospectively analyzed the short- and long-term outcome in polytraumatized patients and the possible influence of RDW values on admission as well as preexisting comorbidities on these outcomes.

Arm

Intervention/Treatment

polytraumatized patients

Patients with an ISS >16 points, an AIS >3 in one body region and at least 2 different body regions affected were included.

Other: retrospective

The investigators retrospectively analyzed the short- and long-term outcome in polytraumatized patients and the possible influence of RDW values on admission as well as preexisting comorbidities on these outcomes.

Outcome Measures

Primary Outcome Measures

In-hospital mortality in polytraumatized patients [January 2012 to December 2015]

Secondary Outcome Measures

Possible influence of RDW values (%) on admission on the long-term outcome [January 2012 to December 2015]
The influence of RDW Values (%) in polytraumatized patients on admission on the long-term outcome (late-phase death (days)) will be examined.

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

ISS >16 points
AIS >3 in one body region
at least 2 body regions affected

Exclusion Criteria:

patients younger than 18 years of age
isolated traumatic brain injury
minor injuries (AIS <3 or ISS <16 points)

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

Medical University of Vienna

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Dr. Valerie Weihs, MD, Medical University of Vienna

ClinicalTrials.gov Identifier:

NCT05221476

Other Study ID Numbers:

RDW Polytrauma

First Posted:

Feb 3, 2022

Last Update Posted:

Feb 3, 2022

Last Verified:

Jan 1, 2022

Individual Participant Data (IPD) Sharing Statement:

Plan to Share IPD:

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Additional relevant MeSH terms:

Multiple Trauma

Study Results

No Results Posted as of Feb 3, 2022